Analysis on expression imbalance of peripheral blood inflammatory cytokines in patients with irritable bowel syndrome

Chinese Journal of Gastroenterology

Volumn 13, Issue 2, 2008, Pages 111-113

  Liang, Haiqing ^a   Wang, Shihe ^a   Li, Yanqing ^a   Wang, Fusheng ^a  

^a Dezhou Municipal People's Hospital   (China)

Author keywords

Cytokines; Enzyme linked immunosorbent assay; Interleukins; Irritable bowel syndrome

Indexed keywords

EID: 79953079407     PISSN: 10087125     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Gwee KA, Leong YL, Graham C, et al. The role of psychological and biological factors in postinfective gut dysfunction. Gut, 1999, 44 (3): 400-406. (Pubitemid 29119338)
2. Chadwick VS, Chen W, Shu D, et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology, 2002, 122 (7): 1778-1783. (Pubitemid 34651421)
3. Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology, 2006, 130 (5): 1377-1390.
4. Wiercinska-Drapalo A, Flisiak R, Jaroszewicz J, et al. Plasma interleukin-18 reflects severity of ulcerative colitis. World J Gastroenterol, 2005, 11 (4): 605-608. (Pubitemid 40185605)
5. Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology, 2005, 129 (2): 550-564. (Pubitemid 41096643)
6. Atreya R, Neurath MF. Involvement of IL-6 in the pathogenesis of inflammatory bowel disease and colon cancer. Clin Rev Allergy Immunol, 2005, 28 (3): 187-196.
7. Minderhoud IM, Oldenburg B, Wismeijer JA, et al. IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior. Dig Dis Sci, 2004, 49 (3): 469-474. (Pubitemid 38453568)
8. Jablonska E, Jablonski J. Effect of IL-18 on the release of IL-6 and its soluble receptors: sIL-6Ralpha and sgp130 by human neutrophils. Immunol Invest, 2002, 31 (3-4): 159-167. (Pubitemid 35397073)
9. Dinan TG, Quigley EM, Ahmed SM, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology, 2006, 130 (2): 304-311. (Pubitemid 43202030)
10. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut, 2003, 52 (4): 523-526. (Pubitemid 36363405)
11. Bercík P, Wang L, Verdú EF, et al. Visceral hyperalgesia and intestinal dysmotility in a mouse model of postinfective gut dysfunction. Gastroenterology, 2004, 127 (1): 179-187. (Pubitemid 38962286)
12. Akiho H, Deng Y, Blennerhassett P, et al. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology, 2005, 129 (1): 131-141. (Pubitemid 41002050)
13. Trudeau J, Hu H, Chibana K, et al. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol, 2006, 117 (6): 1446-1454. (Pubitemid 43795756)
14. Lügering N, Kucharzik T, Kraft M, et al. Interleukin (IL)-13 and IL-4 are potent inhibitors of IL-8 secretion by human intestinal epithelial cells. Dig Dis Sci, 1999, 44 (3): 649-655. (Pubitemid 29137981)
15. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology, 2005, 128 (3): 541-551. (Pubitemid 40585355)
16. Spiller RC. Role of nerves in enteric infection. Gut, 2002, 51 (6): 759-762. (Pubitemid 35408587)